Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Metabolomic Profiling of Kigelia africana Extracts with Anti-Cancer Activity by High Resolution Tandem Mass Spectroscopy

    wadmin2By wadmin2September 18, 2014Updated:August 10, 2021No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Arkhipov, A.1, Sirdaarta, J1,2, Matthews, B3, and Cock, IE1,2*
    1School of Natural Sciences, Griffith University, Brisbane, Australia.
    2Environmental Futures Research Institute, Griffith University, Brisbane, Australia.
    3Smartwaters, Griffith University, Gold Coast, Australia.

    Pharmacognosy Communications,2014,4,4,10-32.
    DOI:10.5530/pc.2014.4.3
    Published:September 2014
    Type:Research Article

    ABSTRACT

    Background: Kigelia africana is an African tree with a wide distribution across southern, central and western Africa. It has a history of therapeutic usage by multiple African ethnic groupings which inhabit the areas in which it grows. Amongst these groups there is a myriad of medicinal uses in the treatment of a wide variety of bacterial, fungal and protozoal infections, as well as in the treatment of inflammation and cancers. This study was undertaken to further examine K. africana fruit extracts for the ability to inhibit cancer cell growth, and to use an unbiased metabolomic profiling approach to detect and putatively identify as many individual components as possible, with the aim of developing a database of identified compounds. Materials and Methods: K. africana fruit powder was extracted and tested for inhibitory activity against the Jeg-3 choriocarcinoma cell line using a colorimetric cell proliferation assay. Toxicity was evaluated using an Artemia franciscana nauplii bioassay. Non-targeted HPLC separation of crude extracts coupled to high resolution time-of-flight (TOF) mass spectroscopy with screening against 3 compound databases was used for the identification and characterisation of individual components in crude plant extracts. Results: The methanol, water and ethyl acetate K. africana fruit extracts displayed significant antiproliferative activity against Jeg-3 choriocarcinoma cells. The methanol and water extracts displayed the strongest anti-proliferative activity, inhibiting Jeg-3 growth to 42% and 46% of the untreated cell growth respectively. The ethyl acetate extract also significantly inhibited Jeg-3 cell proliferation, with decreases to 62% of the untreated control value. Neither the chloroform or hexane extracts had any effect on Jeg-3 cell proliferation. With the exception of the water extract (which displayed moderate toxicity), all extracts were non-toxic or of low toxicity. HPLC-MS/MS TOF analysis identified 356 unique mass signals in the extracts. The putative identities of 227 of these compounds are reported here. Conclusion: This report extends previous studies into the anti-cancer affects of K. africana fruit extracts. The generation of a database of the detected compounds will allow for rapid differentiation of compound profiles between active and less active extracts in future studies. This is expected to assist in the identification of the most important compounds for further separation and bioactivity studies.

    Keywords: Medicinal plants,Bigoniaceae, Sausage tree,  Anti-proliferative activity, Metabolomic profile, LC-MS/ MS, Toxicity, Artemia.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up